Vinorelbine and Gemcitabine in Myeloma
Clinical trial NCT02791373 · COMPLETED
Trial details
- NCT number
- NCT02791373
- Sponsor
- Insel Gruppe AG, University Hospital Bern
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-01
- Primary completion
- 2017-12-31
- Enrollment
- 136
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.